In support of the important role of IL-6 in promoting cancer growth in the bone marrow, blockade of IL-6 by neutralizing antibody as well as inhibition of JAK2 by small-molecule inhibitors significantly blocked tumor growth. This evidence concerns the gene JAK2 and neoplasm.